AddaVax Formulated with PolyI:C as a Potential Adjuvant of MDCK-based Influenza Vaccine Enhances Local, Cellular, and Antibody Protective Immune Response in Mice.

Authors:
Nian X; Zhang J; Deng T; Liu J; Gong Z and 5 more

Journal:
AAPS PharmSciTech

Publication Year: 2021

DOI:
10.1208/s12249-021-02145-0

PMCID:
PMC8584644

PMID:
34766215

Journal Information

Full Title: AAPS PharmSciTech

Abbreviation: AAPS PharmSciTech

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing InterestsThe authors declare no competing interests. Competing Interests The authors declare no competing interests."

Evidence found in paper:

"Funding This work was supported by the National Science and Technology Major Project of “Major New Drug Manufacturing Program” of China (2016ZX09106003-008)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025